Access Market Intell

Access Market Intelligence is a leading source of pharmaceutical and healthcare business information and analyses.

[Access Market Intell @accessmarketint]

AMI will be in Dallas for the NASP conference next week. Let's connect!
#specialtypharmacy #Dallas #conference

[Access Market Intell @accessmarketint]

Walmart reportedly buying majority stake in primary care provider ChenMed seen as a boost to primary clinic business #https://bloom.bg/3ZcZwK8

#Walmart #primarycare #ChenMed #seniorcare

[Access Market Intell @accessmarketint]

Fertility Benefit Solutions 2023-2024 #report offers comprehensive intelligence on the leading market stakeholders https://t.co/6wL2V0EytV
#payers #FBMs #fertilitybenefitmanagers #specialtypharmacy

[Access Market Intell @accessmarketint]

Pharmacy Buying Groups 2023-2024 Report - https://t.co/rPJAFxTQJY

[Access Market Intell @accessmarketint]

Pharmacy Buying Groups 2023-2024 Report - https://t.co/BL6XocN2VN

[Access Market Intell @accessmarketint]

#CVS Caremark and #GoodRx to launch Caremark® Cost Saver™ to help lower out-of-pocket drug costs for CVS Caremark clients' members
#CVSCaremark #CostSaver #generic #drug #pricing https://t.co/odQFoaqBFK

[Access Market Intell @accessmarketint]

Specialty Pharmacy News Roundup: June 2023 available
#specialtypharmacy #news
https://t.co/bsZSKxyy5G

[Access Market Intell @accessmarketint]

Optum's acquisition of Amedisys expands in-home and OptumRx's pharmacy in hospice business
#Optum #OptumRx #amedisys #hospicepharmacy
https://t.co/mnJ73qTnX5

[Access Market Intell @accessmarketint]

#PBM Platform Companies Overview 2023-2024 offers comprehensive intelligence on over 35 companies
#platform #software #technology
https://t.co/elEaRPD4lj

[Access Market Intell @accessmarketint]

#Employers can spark a movement to help us live longer and healthier lives bu driving change
#healthcare #spending #benefits
https://t.co/Dx1HgibGh9

[Access Market Intell @accessmarketint]

#FDA Braces for Looming Boom in Cell and Gene Therapy Submissions https://t.co/pvvQ7o7ZOO
#celltherapy #genetherapy
https://t.co/immDY20K4A

[Access Market Intell @accessmarketint]

#Employer perspective covering various topics and issues related to healthcare pathways
#healthcare #clinical #pathways
https://t.co/tytNJ5SJZd

[Access Market Intell @accessmarketint]

Osteopathic physicians, commonly known as #DOs, taking up the slack in rural primary care
#primarycare #rural #physician #Osteopathic
https://t.co/o9vj6WDnDq

[Access Market Intell @accessmarketint]

AMI’s 2023-2024 #GPO Annual Review provides company profiles on the leading 65 GPOs, all in one resource https://t.co/OAyoWiY6mg
#grouppurchasing #supplychain #AMI

[Access Market Intell @accessmarketint]

Walgreens asked a U.S. judge to vacate an arbitrator's award of more than $642 million to Humana in a drug-pricing dispute
#Walgreens #Humana #drugpricing
https://t.co/e31UT4KpPT

[Access Market Intell @accessmarketint]

#FDA approval of #Chiesi and #Protalix #Elfabrio for Fabry disease offers the market another therapy
#FabryDisease #therapy
https://t.co/rSiSE3bGrK

[Access Market Intell @accessmarketint]

Million dollar claims increasing among employer plans, according to a new report from Sun Life
#employer #benefits #specialtydrug #claims
https://t.co/i3t8n4kaBq

[Access Market Intell @accessmarketint]

PBM reform remains in the news. New ebookexplains the complex world of managed pharmacy benefits
#pbm #pbmreform #transparency #Senate #pharmacybenefit

[Access Market Intell @accessmarketint]

Scrutiny increases on lack of transparency in contracting by Drug Rebate Aggregators that are passed on to PBMs
#rebateaggregator #drugrebate #PBM #transparency #contracting
https://t.co/ZjEJP5iaRu

[Access Market Intell @accessmarketint]

Cell & Gene Therapy Financing Solutions 2023 Review - https://t.co/QgipFaqySC